Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2023-06-08 Major Shareholding Noti…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
112年年報及股東會資料 — 2023_3164_20230530F17.pdf
Major Shareholding Notification Classification · 95% confidence The document contains a table listing the top ten shareholders of a company, including their shareholdings and relationships among them (e.g., family ties). This is a typical format for a Major Shareholding Notification, which reports changes or details about significant shareholders and their relationships. The document is short (1043 characters) and does not contain financial statements or management discussion, so it is not an Annual Report or Interim Report. It is not a voting result, board change, or other categories. Therefore, the best fit is Major Shareholding Notification (MRQ).
2023-06-08 Chinese
112年年報及股東會資料 — 2022_3164_20230530F04.pdf
Annual Report Classification · 100% confidence The document is titled as an annual report for the fiscal year (一一一年度年報) and includes detailed sections such as shareholder reports, company governance, financial data, capital and shares information, operational overview, and other comprehensive disclosures typical of a full annual report. It also includes auditor information and detailed governance and remuneration disclosures. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed financial and operational data confirms it is not merely a publication announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2022
2023-06-08 Chinese
112年年報及股東會資料 — 2023_3164_20230530F02.pdf
AGM Information Classification · 100% confidence The document is a detailed shareholder meeting manual for GenMont Biotech Inc., specifically for the Annual General Meeting (AGM) held on May 30, 2023 (Republic of China year 112). It includes the meeting agenda, reports, election of directors, and other shareholder matters. The document contains attachments such as the 111th fiscal year (2022) business report, audit committee review report, auditor's report, financial statements, profit distribution table, and director candidate list. The content is comprehensive and includes financial data, audit opinions, and governance details, all typical of materials prepared for an AGM. The presence of detailed meeting procedures, agenda items, and attachments for shareholder review aligns with the definition of AGM Information (AGM-R). It is not just an announcement or a proxy statement but the actual meeting materials and reports used during the AGM. Therefore, the correct classification is AGM Information (AGM-R).
2023-06-08 Chinese
112年年報及股東會資料 — 2023_3164_20230530F13.pdf
AGM Information Classification · 95% confidence The document is titled as materials related to the 112th Annual General Meeting (AGM) of GenMont Biotech Inc. It includes agenda items such as the 111th fiscal year business report, financial statements, profit distribution, election of directors, and other shareholder meeting matters. The document is structured as meeting materials and explanations for shareholders to review during the AGM. It is not the full annual report or financial statements themselves but rather the information and proposals presented at the AGM. The presence of agenda items, voting proposals, and meeting logistics confirms this is AGM Information.
2023-06-08 Chinese
112年年報及股東會資料 — 2023_3164_20230530F01.pdf
AGM Information Classification · 95% confidence The document is a notification for the 112th Annual General Meeting (股東常會通知) of 景岳生物科技股份有限公司, including details about electronic voting, proxy forms, meeting date, location, and instructions for shareholders. It does not contain financial statements or results but is clearly a meeting notice and related materials for the AGM. The document length is substantial but the content is focused on the AGM logistics and shareholder voting procedures, not the actual meeting results or presentations. Therefore, it fits the category of AGM Information (AGM-R).
2023-06-08 Chinese
112年05月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, chairman, general manager, and other executives, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, which is typical of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document length is sufficient to be a full report, not just an announcement. Therefore, the document is best classified as a Director's Dealing report.
2023-06-06 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.